Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
COVID; COVID; he came positive for COVID, this was the second time he had COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A male patient in his 70's received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID"; DISEASE RECURRENCE (medically significant), outcome "unknown", described as "he came positive for COVID, this was the second time he had COVID". The clinical course was reported as follows: The patient's wife took her husband to the emergency room where he came positive for COVID, so they sent a medication to the pharmacy. She also reported since the vaccine came out; he always used Pfizer. The patient was previously given nirmatrelvir, ritonavir (PAXLOVID). The event "he came positive for covid, this was the second time he had covid" required emergency room visit. The patient underwent the laboratory tests and procedures as aforementioned. Therapeutic measures were taken as a result of covid-19, drug ineffective.
Test Name: COVID; Test Result: Positive